Since its founding in 2012, SDS Life Science has grown into a multi-disciplinary team of handpicked specialists with regulatory and scientific knowledge in medicinal product development and statistics. Our ambition is to guide our clients in transforming their research hypotheses into full clinical studies. We adopt a holistic approach in collaboration with our clients to provide the best solutions for each unique project. Our passion is to solve those tricky questions which have no obvious answers. Since 2022, the SDS group is part of Cytel Inc.
SDS Life Science is now a part of Cytel Inc.
Cytel Inc, a leading provider of statistical software and advanced analytics tools for clinical study design, has agreed to acquire SDS Life Science AB
Regulatory and commercial success starts here
Developing a successful drug requires a clear and effective strategy that addresses the needs of investors, regulatory agencies, and your development team.
Target Product Profile | TPP
What is Real World Evidence - and why do we need it?
It is essential to conduct randomized controlled studies in drug development. However, these are not always sufficient to get approval from regulatory bodies.
A One-Stop Shop for Drug Development
Welcome to SDS Life Science
Learn more about us
Target Product Profile
Developing a successful drug requires more than a great idea - it requires a clear and effective strategy that addresses the needs of investors, regulatory agencies, and your development team. Without a well-defined target product profile, you risk losing precious time and resources on ineffective or misaligned strategies.
Who we serve